Ripple kopen? Dit zijn de mogelijkheden

Becton, Dickinson & Aandeel

268,72USD 3,28USD 1,24%

Becton, Dickinson & Grafiek - 1 Jaar - NYSE

Taxaties voor Becton, Dickinson &

KPI 2019 2020e 2021e 2022e 2023e
Dividend - 3,58 3,87 4,40 -
Dividendrendement (in %) - - - - -
K/W-verhouding - - - - -
Winst/Aandeel 11,68 12,58 14,00 15,32 -

Nieuws voor Becton, Dickinson & Co. (BD)

Geen nieuws beschikbaar
Meer nieuws

Analisten over Becton, Dickinson & Co. (BD)

meer analisten

Becton, Dickinson & Peer Group

Becton, Dickinson & 268,72
CR Bard 0,00
Covidien 0,00
Fresenius Medical Care 66,11
Fresenius 50,85
Gen-Probe 0,00
Thermo Fisher Scientific 320,50

Invoer toevoegen

Wat denkt u?

Profiel Becton, Dickinson & Co. (BD)naar bedrijfsprofiel

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Realtime koers Becton, Dickinson & Co. (BD)

Beurs BTT

Aandelenkoers Becton, Dickinson & Co. (BD) in USDPush activeren

Koers 268,72 USD 3,28 1,24 %
Tijd 22:15:10
Handelsdatum 13.12.2019
Opening 265,13
Slot 265,44
Hoogste 269,38
Laagste 264,17
52 W. Hoog 269,38
52 W. Laag 208,67
52 W. Perf.
Volume (Aantal) 454.037
Marktkap. (EUR) 66,32 Mrd
De koers van 268,72 USD aan de beurs New York komt bij de actuele wisselkoers overeen USD/EUR met een koers van 241,66 Euro.

Naar aandeel Becton, Dickinson &

ISIN US0758871091
Indices S&P 500

Becton, Dickinson & Kerncijfers

Marktkapitalisatie in Euro 66,32 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 270,46
Kasstroom/Aandeel in lokale valuta 13,81
Boekwaarde/Aandeel in lokale valuta
60 Dagen Volatiliteit 20,22
K/B verhouding

Becton, Dickinson & Historische koersen

12-12-2019 265,44 413.684
11-12-2019 261,06 256.458
10-12-2019 257,24 257.078
9-12-2019 257,90 261.406
6-12-2019 260,69 223.212

Aandelen in dezelfde sector met betere 1J Perf.